Response to comment on: Draznin et al. Pathways to quality inpatient management of hyperglycemia and diabetes: a call to action. Diabetes Care 2013;36:1807-1814.

We are pleased to hear from our British colleagues who agreed with our call to action to engage in more clinical research in order to generate data supporting the benefit of glycemic control in hospitalized patients with diabetes (1,2). This paucity of clinical evidence was indeed the impetus for organizing our consortium PRIDE (Planning Research in Inpatient Diabetes).

It is gratifying to learn that three major U.K. diabetes associations developed and posted online a series of national guidelines on management of inpatient diabetes (3). A similar effort in the U.S. was presented by the American Association of Clinical Endocrinologists, American Diabetes Association, and Society of Hospital Medicine, which took this task very seriously (4,5).

The task of PRIDE is not to duplicate this effort but rather to develop clinical research in this field that can become a foundation for evidence-based guidelines used not only on both sides of the pond but in the rest of the world as well.